Thioguanine

CHEMBL727 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
167.2 g/mol
LogP
-0.1
Phase
4

This chemotherapy medication interferes with DNA synthesis in rapidly dividing cancer cells and is used to treat certain types of leukemia. It belongs to the thiopurine class and is converted inside cells into compounds that block DNA and RNA production. Regular blood count monitoring is essential as it can significantly suppress the bone marrow.

分子量

167.1900 g/mol

LogP

-0.10

TPSA

111.00 Ų

リピンスキーの五則

適合

治療領域

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Nc1nc2[nH]cnc2c(=S)[nH]1

InChI

InChI=1S/C5H5N5S/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)

Molecular Formula

C5H5N5S

HBD / HBA

3 / 2

回転可能結合数

0

重原子数

11

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

This chemotherapy medication interferes with DNA synthesis in rapidly dividing cancer cells and is used to treat certain types of leukemia. It belongs to the thiopurine class and is converted inside cells into compounds that block DNA and RNA production. Regular blood count monitoring is essential as it can significantly suppress the bone marrow.

Yes, Thioguanine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL727. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 2723601. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.